Published in AIDS Weekly, April 28th, 2003
"The correlation of anti-Vpu antibody (Ab) reactivity to Vpu and AIDS disease progression was studied in 162 HIV-1/AIDS patients after they had received highly active antiretroviral therapy (HAART) for one year," according to Y.M.A. Chen and coauthors at National Yang-Ming University. "Anti-Vpu Ab reactivity was analyzed by Western blot using a recombinant Vpu protein."
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of AIDS Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.